Faize Yüksel

524 total citations
31 papers, 434 citations indexed

About

Faize Yüksel is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Faize Yüksel has authored 31 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 13 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Faize Yüksel's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Thyroid Disorders and Treatments (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Faize Yüksel is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Thyroid Disorders and Treatments (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). Faize Yüksel collaborates with scholars based in Türkiye, Tunisia and United States. Faize Yüksel's co-authors include Mehmet Ali Özcan, Sena Yeşil, Barış Akıncı, Serkan Yener, Tevfik Demir, Abdurrahman Çömlekçi, Fatih Demırkan, Mustafa Seçil, Fırat Bayraktar and Aygül Çeltik and has published in prestigious journals such as Blood, The American Journal of Cardiology and Metabolism.

In The Last Decade

Faize Yüksel

31 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faize Yüksel Türkiye 14 124 103 90 80 71 31 434
Cristina Falcó Spain 16 98 0.8× 219 2.1× 84 0.9× 50 0.6× 126 1.8× 19 567
Mehmet Erdoğan Türkiye 17 392 3.2× 67 0.7× 95 1.1× 127 1.6× 70 1.0× 58 780
Mária Škereňová Slovakia 14 30 0.2× 147 1.4× 42 0.5× 58 0.7× 85 1.2× 50 457
Anna Di Blasio Italy 9 81 0.7× 37 0.4× 84 0.9× 71 0.9× 94 1.3× 17 500
Sarra Saidi Tunisia 13 42 0.3× 156 1.5× 37 0.4× 39 0.5× 88 1.2× 16 388
Alex E. Henney United Kingdom 6 46 0.4× 210 2.0× 76 0.8× 63 0.8× 57 0.8× 10 473
Zhao Bingrang China 7 29 0.2× 53 0.5× 90 1.0× 120 1.5× 67 0.9× 14 416
I Canavy France 6 32 0.3× 69 0.7× 97 1.1× 157 2.0× 148 2.1× 10 422
Zhaohui Wang China 15 50 0.4× 48 0.5× 77 0.9× 153 1.9× 118 1.7× 53 599
M. Karadeniz Türkiye 15 216 1.7× 19 0.2× 99 1.1× 80 1.0× 70 1.0× 25 479

Countries citing papers authored by Faize Yüksel

Since Specialization
Citations

This map shows the geographic impact of Faize Yüksel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faize Yüksel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faize Yüksel more than expected).

Fields of papers citing papers by Faize Yüksel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faize Yüksel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faize Yüksel. The network helps show where Faize Yüksel may publish in the future.

Co-authorship network of co-authors of Faize Yüksel

This figure shows the co-authorship network connecting the top 25 collaborators of Faize Yüksel. A scholar is included among the top collaborators of Faize Yüksel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faize Yüksel. Faize Yüksel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sevindik, Ömür Gökmen, Faize Yüksel, Mehmet Ali Özcan, et al.. (2018). Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?. Turkish Journal of Hematology. 35(4). 271–276. 3 indexed citations
2.
Özcan, Mehmet Ali, et al.. (2016). Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma. Experimental Hematology. 44(4). 223–230. 6 indexed citations
3.
Akıncı, Barış, et al.. (2014). Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid. Journal of Diabetes and its Complications. 28(6). 844–849. 6 indexed citations
4.
Gözmen, Salih, Özlem Tüfekçi, Canan Vergin, et al.. (2014). B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood. Blood Coagulation & Fibrinolysis. 27(5). 494–499. 8 indexed citations
5.
Tüfekçi, Özlem, Salih Gözmen, Faize Yüksel, et al.. (2013). The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy. Blood Coagulation & Fibrinolysis. 24(4). 375–380. 2 indexed citations
6.
Akıncı, Barış, Aygül Çeltik, Sinan Genç, et al.. (2013). Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes. Archives of Gynecology and Obstetrics. 289(4). 787–793. 20 indexed citations
7.
Yener, Serkan, et al.. (2011). Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas. European Journal of Internal Medicine. 23(1). 83–87. 13 indexed citations
8.
Akıncı, Barış, Tevfik Demir, Abdurrahman Çömlekçi, et al.. (2010). Effect of Levothyroxine Suppression Therapy on Plasma Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels in Benign Thyroid Nodules. Medical Principles and Practice. 20(1). 23–28. 5 indexed citations
9.
Akıncı, Barış, Aygül Çeltik, Faize Yüksel, et al.. (2010). Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. Diabetes Research and Clinical Practice. 91(1). 26–31. 35 indexed citations
10.
Bediz, Cem Şeref, et al.. (2010). The Effect of the Acute Submaximal Exercise on Thrombin Activatable Fibrinolysis Inhibitor Levels in Young Sedentary Males. Clinical and Applied Thrombosis/Hemostasis. 17(4). 414–420. 11 indexed citations
11.
Demir, Tevfik, Barış Akıncı, Abdurrahman Çömlekçi, et al.. (2009). Levothyroxine suppression treatment for benign thyroid nodules alters coagulation. 20. 1 indexed citations
12.
Yener, Serkan, Abdurrahman Çömlekçi, Barış Akıncı, et al.. (2009). Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications. Medical Principles and Practice. 18(4). 266–271. 14 indexed citations
13.
Bayraktar, Fırat, Dilek Solmaz, Hülya Ellıdokuz, et al.. (2009). Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome. Metabolism. 59(3). 305–313. 28 indexed citations
14.
Akıncı, Barış, Tevfik Demir, Aygül Çeltik, et al.. (2008). Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. Diabetes Research and Clinical Practice. 82(2). 172–178. 42 indexed citations
15.
Demir, Tevfik, Barış Akıncı, Abdurrahman Çömlekçi, et al.. (2008). Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation. Clinical Endocrinology. 71(3). 446–450. 9 indexed citations
16.
Akıncı, Barış, Abdurrahman Çömlekçi, Serkan Yener, et al.. (2008). Hashimoto's Thyroiditis, but not Treatment of Hypothyroidism, Is Associated with Altered TGF-β1 Levels. Archives of Medical Research. 39(4). 397–401. 28 indexed citations
17.
Akıncı, Barış, Abdurrahman Çömlekçi, Serkan Yener, et al.. (2007). The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism. HORMONES. 6(4). 327–333. 10 indexed citations
18.
Güneri, Sema, Bahri Akdeniz, Mehmet Ali Özcan, et al.. (2005). Usefulness of Preprocedural Soluble CD40 Ligand for Predicting Restenosis After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. The American Journal of Cardiology. 97(2). 198–202. 32 indexed citations
19.
Özcan, Mehmet Ali, Abdurrahman Çömlekçi, Fatih Demırkan, et al.. (2003). Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thrombosis Research. 110(4). 243–247. 19 indexed citations
20.
Akarsu, Mesut, Fatih Demırkan, Fatoş Önen, et al.. (2001). Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease. American Journal of Hematology. 68(4). 225–230. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Falcó Breakdown of academic impact, for papers by Mehmet Erdoğan Breakdown of academic impact, for papers by Mária Škereňová Breakdown of academic impact, for papers by Anna Di Blasio Breakdown of academic impact, for papers by Sarra Saidi Breakdown of academic impact, for papers by Alex E. Henney Breakdown of academic impact, for papers by Zhao Bingrang Breakdown of academic impact, for papers by I Canavy Breakdown of academic impact, for papers by Zhaohui Wang Breakdown of academic impact, for papers by M. Karadeniz
Rankless by CCL
2026